Cargando…

Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma

Emerging evidence revealed the critical roles of long non-coding RNAs (lncRNAs) in maintaining genomic instability. However, genome instability-associated lncRNAs (GILncRNAs) and their performance in clinical prognostic significance in hepatocellular carcinoma (HCC) are rarely reported. Our study co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dan-Ping, Liao, Mian-Mian, Tong, Jing-Jing, Yuan, Wei-Qu, Peng, De-Ti, Lai, Jian-Ping, Zeng, Yi-Hao, Qiu, Yi-Jun, Tong, Guang-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660619/ https://www.ncbi.nlm.nih.gov/pubmed/34799469 http://dx.doi.org/10.18632/aging.203698

Ejemplares similares

Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
por: Zhu, Yinghui, et al.
Publicado: (2022)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

A 9-lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus-positive hepatocellular carcinoma
por: Liu, Honghong, et al.
Publicado: (2019)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
por: Lian, Jie, et al.
Publicado: (2022)

Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2021)

The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma
por: Mo, Han, et al.
Publicado: (2022)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity
por: Feng, Chun, et al.
Publicado: (2018)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
por: Yang, Huijie, et al.
Publicado: (2022)

Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma
por: Lu, Dingyu, et al.
Publicado: (2023)

The lncRNA Neat1 promotes activation of inflammasomes in macrophages
por: Zhang, Pengfei, et al.
Publicado: (2019)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer
por: Jiao, Ying, et al.
Publicado: (2022)

Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer
por: Yin, Tengfei, et al.
Publicado: (2021)

The Potential Regulatory Mechanism of lncRNA 122K13.12 and lncRNA 326C3.7 in Ankylosing Spondylitis
por: Wang, Jian-xiong, et al.
Publicado: (2021)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
por: Hong, Weifeng, et al.
Publicado: (2020)

The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis
por: Yang, Ming-li, et al.
Publicado: (2018)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
por: Kong, Qinglei, et al.
Publicado: (2019)

Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma
por: Wang, Lin, et al.
Publicado: (2022)

Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma
por: Huang, Yi, et al.
Publicado: (2023)

A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer
por: Song, Jia-Yi, et al.
Publicado: (2020)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2021)

Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer
por: Sun, Jie, et al.
Publicado: (2021)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape
por: Zhan, Tian, et al.
Publicado: (2023)

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription
por: Kang, Chun Lan, et al.
Publicado: (2019)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_77t70d0abi5n9o4a8sr2eucq38